Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Targeting the PGI2 pathway may help heal diabetic foot ulcers.

New compounds may help treat heart disease by activating specific potassium channels.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

New progesterone-based compounds can block male hormones.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Analog 23 is a promising compound for prostate cancer treatment.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Compound 6 is a promising candidate for better wound healing.

Drugs like PDEI may help hair disorders like AGA.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.